A detailed history of Baird Financial Group, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Baird Financial Group, Inc. holds 1,944,307 shares of ABT stock, worth $220 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares
1,944,307
Previous 2,051,274 5.21%
Holding current value
$220 Million
Previous $213 Million 4.0%
% of portfolio
0.44%
Previous 0.45%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$100.07 - $118.13 $10.7 Million - $12.6 Million
-106,967 Reduced 5.21%
1,944,307 $222 Million
Q2 2024

Aug 13, 2024

BUY
$100.73 - $112.44 $2.15 Million - $2.4 Million
21,365 Added 1.05%
2,051,274 $213 Million
Q1 2024

May 14, 2024

SELL
$109.52 - $120.96 $275,442 - $304,214
-2,515 Reduced 0.12%
2,029,909 $231 Million
Q4 2023

Feb 14, 2024

BUY
$90.19 - $110.4 $26.9 Million - $32.9 Million
297,789 Added 17.17%
2,032,424 $224 Million
Q3 2023

Nov 13, 2023

SELL
$95.53 - $114.62 $1.62 Million - $1.94 Million
-16,959 Reduced 0.97%
1,734,635 $168 Million
Q2 2023

Aug 11, 2023

SELL
$100.78 - $112.29 $30 Million - $33.4 Million
-297,424 Reduced 14.52%
1,751,594 $191 Million
Q1 2023

May 15, 2023

BUY
$96.86 - $114.01 $3.87 Million - $4.56 Million
39,970 Added 1.99%
2,049,018 $207 Million
Q3 2022

Nov 14, 2022

SELL
$96.76 - $112.03 $3.51 Million - $4.07 Million
-36,324 Reduced 1.78%
2,008,847 $194 Million
Q2 2022

Aug 08, 2022

BUY
$102.07 - $123.37 $1.7 Million - $2.06 Million
16,666 Added 0.82%
2,045,171 $222 Million
Q1 2022

May 13, 2022

BUY
$114.02 - $139.04 $2.09 Million - $2.55 Million
18,316 Added 0.91%
2,028,505 $240 Million
Q4 2021

Feb 09, 2022

SELL
$115.53 - $141.46 $1.67 Million - $2.04 Million
-14,433 Reduced 0.71%
2,010,189 $283 Million
Q3 2021

Nov 12, 2021

SELL
$116.66 - $129.06 $11.8 Million - $13 Million
-100,956 Reduced 4.75%
2,024,622 $239 Million
Q2 2021

Aug 11, 2021

BUY
$105.79 - $124.53 $7.53 Million - $8.87 Million
71,220 Added 3.47%
2,125,578 $246 Million
Q1 2021

May 13, 2021

BUY
$108.84 - $128.23 $8.08 Million - $9.52 Million
74,278 Added 3.75%
2,054,358 $246 Million
Q4 2020

Feb 11, 2021

SELL
$105.0 - $114.42 $2.21 Million - $2.41 Million
-21,025 Reduced 1.05%
1,980,080 $217 Million
Q3 2020

Nov 12, 2020

BUY
$91.64 - $111.29 $287,199 - $348,782
3,134 Added 0.16%
2,001,105 $218 Million
Q2 2020

Oct 22, 2020

BUY
$76.57 - $98.0 $10 Million - $12.8 Million
130,641 Added 7.0%
1,997,971 $183 Million
Q2 2020

Aug 14, 2020

SELL
$76.57 - $98.0 $6,508 - $8,330
-85 Reduced -0.0%
1,867,330 $163 Million
Q1 2020

May 14, 2020

SELL
$62.82 - $91.86 $2.61 Million - $3.82 Million
-41,559 Reduced 2.18%
1,867,415 $147 Million
Q4 2019

Feb 14, 2020

BUY
$78.51 - $87.4 $945,181 - $1.05 Million
12,039 Added 0.63%
1,908,974 $166 Million
Q3 2019

Nov 14, 2019

BUY
$81.84 - $88.74 $1.85 Million - $2.01 Million
22,653 Added 1.21%
1,896,935 $159 Million
Q2 2019

Aug 14, 2019

BUY
$72.88 - $85.0 $24.5 Million - $28.5 Million
335,730 Added 21.82%
1,874,282 $158 Million
Q1 2019

May 14, 2019

BUY
$66.22 - $80.06 $4.09 Million - $4.94 Million
61,746 Added 4.18%
1,538,552 $123 Million
Q4 2018

Feb 14, 2019

BUY
$65.56 - $74.27 $17.9 Million - $20.3 Million
273,412 Added 22.72%
1,476,806 $107 Million
Q3 2018

Nov 13, 2018

BUY
$60.81 - $73.36 $485,081 - $585,192
7,977 Added 0.67%
1,203,394 $89.2 Million
Q2 2018

Aug 13, 2018

BUY
$57.57 - $63.54 $531,313 - $586,410
9,229 Added 0.78%
1,195,417 $72.8 Million
Q1 2018

May 14, 2018

BUY
$56.27 - $63.62 $591,847 - $669,155
10,518 Added 0.89%
1,186,188 $71.1 Million
Q4 2017

Feb 09, 2018

BUY
$53.68 - $57.47 $757,317 - $810,786
14,108 Added 1.21%
1,175,670 $67.1 Million
Q3 2017

Nov 14, 2017

BUY
$48.06 - $53.64 $1.13 Million - $1.26 Million
23,414 Added 2.06%
1,161,562 $62 Million
Q2 2017

Aug 14, 2017

BUY
N/A
1,138,148
1,138,148 $55.3 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $199B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Baird Financial Group, Inc. Portfolio

Follow Baird Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Baird Financial Group, Inc. with notifications on news.